CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 192 filers reported holding CYTOKINETICS INC in Q2 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $823,598 | +20.7% | 27,957 | +33.7% | 0.00% | – |
| Q2 2023 | $682,198 | -9.2% | 20,914 | -2.0% | 0.00% | – |
| Q1 2023 | $751,078 | -22.9% | 21,344 | +0.3% | 0.00% | -100.0% |
| Q4 2022 | $974,683 | -15.0% | 21,272 | -10.1% | 0.00% | 0.0% |
| Q3 2022 | $1,147,000 | +21.5% | 23,671 | -1.5% | 0.00% | 0.0% |
| Q2 2022 | $944,000 | +29.3% | 24,036 | +21.2% | 0.00% | – |
| Q1 2022 | $730,000 | -13.0% | 19,834 | +7.7% | 0.00% | – |
| Q4 2021 | $839,000 | +49.0% | 18,415 | +16.8% | 0.00% | – |
| Q3 2021 | $563,000 | +39.0% | 15,765 | -23.0% | 0.00% | – |
| Q2 2021 | $405,000 | -7.3% | 20,477 | +8.9% | 0.00% | – |
| Q1 2021 | $437,000 | +76.9% | 18,797 | +58.0% | 0.00% | – |
| Q4 2020 | $247,000 | -16.3% | 11,897 | -12.8% | 0.00% | – |
| Q3 2020 | $295,000 | -1.7% | 13,639 | +7.0% | 0.00% | – |
| Q2 2020 | $300,000 | +26.6% | 12,745 | -36.6% | 0.00% | – |
| Q1 2020 | $237,000 | – | 20,104 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 4,989,218 | $47,348,000 | 10.09% |
| EcoR1 Capital, LLC | 2,139,697 | $20,306,000 | 8.01% |
| Healthcare Value Capital, LLC | 100,000 | $949,000 | 1.15% |
| DAFNA Capital Management LLC | 150,000 | $1,424,000 | 1.13% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 151,106 | $1,434,000 | 1.07% |
| Avoro Capital Advisors LLC | 503,900 | $4,782,000 | 1.06% |
| ACUTA CAPITAL PARTNERS, LLC | 140,969 | $1,338,000 | 0.64% |
| Iguana Healthcare Management, LLC | 150,000 | $1,424,000 | 0.58% |
| WASATCH ADVISORS LP | 1,746,096 | $16,570,000 | 0.25% |
| Virtus ETF Advisers LLC | 29,379 | $279,000 | 0.21% |